Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TS03 Inc Trust Units TSTIF

Healthcare Medical Instruments & Supplies


GREY:TSTIF - Post by User

TS03 Inc Trust Units > Shareholder Value
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(15)
•••
Comment by Dr.Cashon Feb 05, 2019 1:10pm
128 Views
Post# 29321440

RE:RE:RE:RE:Shareholder Value

RE:RE:RE:RE:Shareholder ValueIman,  I am sorry I offended you.  You may have misunderstood what I meant when I said clowns. I was referring to the members on this Stockhouse board that spend so much time whining about TSO3  and how poor the  performance has been but keep hanging around instead of selling.  The members that take this order to a personal level and want to throw out Rumble but have not got a clue who they would put back in. I hope that Clarifies clown or are you?
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities